1-Dec-2008
Subscription Info
|
Institutional Access
|
Browse the Faculties
|
Free Trial
|
Take a Tour
|
Top 10s
|
Advanced Search
|
Faculty Member List
|
About
Search
All F1000 Medicine
Cardiovascular D...
Top 10s
Cardiovascular Disorders
Current Top 10 by F1000 Factor
All Time Top 10 by F1000 Factor
Most viewed Top 10
(from all journals)
Most viewed Top 10
(from specialty journals)
Hidden Jewels
Sections Covered
Arrhythmias, Electrophysiology & Pacing
Cardiovascular Imaging
Congenital Heart Disease
Coronary Artery Disease
Geriatric Cardiology
Heart Failure
Hypertension
Valvular Disease
Vascular Diseases (Non-Coronary)
Related Sections
Acute Cardiovascular Problems
Hemodynamics, Vasc. Biology & Hypertension Sec. to Kidney Dis.
Pulmonary Vascular Diseases
ALL TIME TOP 10 BY F1000 FACTOR | Cardiovascular Disorders | calculated on 1 December 2008
All Time Top 10 By F1000 Factors are generated every day using papers added to F1000 Medicine since the project started (Top 10s consider papers evaluated in the preceding month). Papers are ranked according to their
F1000 Factor
which incorporates both the number of times a paper has been evaluated, and the ratings it received. If any papers have an equal F1000 Factor then the most recently added paper is listed first.
browse faculty
| show All Time Top 10 in
ALL OF MEDICINE
Anesthesiology & Pain Management
Cardiovascular Disorders
Critical Care & Emergency Medicine
Dermatology
Diabetes & Endocrinology
Gastroenterology & Hepatology
Hematology
Infectious Diseases
Nephrology
Neurological Disorders
Oncology
Psychiatry
Public Health & Epidemiology
Research Methodology
Respiratory Disorders
Rheumatology & Clinical Immunology
Urology
Women's Health
selected articles
all 10 items
to
EndNote
Ref. Manager
RefWorks
Bibtex
ProCite
email [
Help
]
1
Exceptional
F1000 Factor
10.7
Changes
Clinical Practice
Confirmation
New Finding
Treatment of hypertension in patients 80 years of age or older.
Beckett NS, Peters R, …, Bulpitt CJ, HYVET Study Group
N Engl J Med
2008 May 1
358
(18):1887-98 [
abstract on PubMed
] [
related articles
] [
FREE full text
]
Selected by
| Deepak Bhatt with Dharam Kumbhani / Ramachandran S. Vasan / Jerome Fleg / Annemarie Hennessy / Ernesto Schiffrin / Wilbert Aronow / Kazuomi Kario with Joji Ishikawa
First evaluation 14 Apr 2008 | Latest evaluation 3 Jun 2008
2
Exceptional
F1000 Factor
10.0
Confirmation
New Finding
Controversial
Telmisartan, ramipril, or both in patients at high risk for vascular events.
ONTARGET Investigators, Yusuf S, …, Sleight P, Anderson C
N Engl J Med
2008 Apr 10
358
(15):1547-59 [
abstract on PubMed
] [
related articles
] [
FREE full text
]
Selected by
| Csaba Kovesdy / Sripal Bangalore / Enyu Imai / Ernie Esquivel
First evaluation 15 Apr 2008 | Latest evaluation 14 May 2008
3
Exceptional
F1000 Factor
9.8
Changes
Clinical Practice
Confirmation
Hypothesis
New Finding
Controversial
Rhythm control versus rate control for atrial fibrillation and heart failure.
Roy D, Talajic M, …, Waldo AL, Atrial Fibrillation and Congestive Heart Failure Investigators
N Engl J Med
2008 Jun 19
358
(25):2667-77 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Brian Olshansky with Chirag Sandesara / Wilbert Aronow / Hector Ventura with Anil Verma
First evaluation 15 Jul 2008 | Latest evaluation 11 Aug 2008
4
Exceptional
F1000 Factor
9.0
New Finding
Controversial
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein.
Ridker PM, Danielson E, …, Glynn RJ, the JUPITER Study Group
N Engl J Med
2008 Nov 20
359
(21):2195-2207 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Melvin Cheitlin
Evaluated 28 Nov 2008
5
Exceptional
F1000 Factor
9.0
Changes
Clinical Practice
Confirmation
The effect of hematocrit during hypothermic cardiopulmonary bypass in infant heart surgery: results from the combined Boston hematocrit trials.
Wypij D, Jonas RA, …, Laussen PC, Newburger JW
J Thorac Cardiovasc Surg
2008 Feb
135
(2):355-60 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| James Tweddell
Evaluated 2 Sep 2008
6
Exceptional
F1000 Factor
9.0
Hypothesis
Prognostic role of flow-mediated dilatation of the brachial artery in hypertensive patients.
Muiesan ML, Salvetti M, …, Castellano M, Agabiti-Rosei E
J Hypertens
2008 Aug
26
(8):1612-8 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Tomasz Grodzicki
Evaluated 28 Jul 2008
7
Exceptional
F1000 Factor
9.0
New Finding
Contemporary outcomes after the Fontan procedure: a Pediatric Heart Network multicenter study.
Anderson PA, Sleeper LA, …, Clark BJ, Pediatric Heart Network Investigators
J Am Coll Cardiol
2008 Jul 8
52
(2):85-98 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Luc Mertens
Evaluated 22 Jul 2008
8
Exceptional
F1000 Factor
9.0
New Finding
G12-G13-LARG-mediated signaling in vascular smooth muscle is required for salt-induced hypertension.
Wirth A, Benyó Z, …, Gutkind JS, Offermanns S
Nat Med
2008 Jan
14
(1):64-8 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Michael Boschmann
Evaluated 16 Jul 2008
9
Exceptional
F1000 Factor
9.0
Changes
Clinical Practice
Tech Advance
A percutaneous technique for preservation of arch branch patency during thoracic endovascular aortic repair (TEVAR): retrograde catheterization and stenting.
Criado FJ
J Endovasc Ther
2007 Feb
14
(1):54-8 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Lefeng Qu
Evaluated 1 Jul 2008
10
Exceptional
F1000 Factor
9.0
New Finding
Central pressure: variability and impact of cardiovascular risk factors: the Anglo-Cardiff Collaborative Trial II.
McEniery CM, Yasmin , …, Wilkinson IB, Anglo-Cardiff Collaborative Trial Investigators
Hypertension
2008 Jun
51
(6):1476-82 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Raymond Townsend
Evaluated 13 Jun 2008
© 2008 Medicine Reports Ltd unless otherwise stated.
< info@f1000.com >
Terms and conditions
Legal info